Heather Rosecrans
Greenleaf Health, USA
Posters & Accepted Abstracts: J Pharmacovigil
Approximately 95% of medical devices in the USA today are marketed under the Premarket Notification 510(k) requirements of the US Food, Drug, and Cosmetic Act. This session will provide the latest developments in the 510(k) review process with helpful tips on corresponding optimal regulatory strategy, when and how to contact the US Food and Drug Administration, and how to optimize opportunities for a predictable 510(k) review experience. The session will focus on a robust baseline in the fundamentals of 510(k) submissions, from underlying regulations to unique regulatory concepts, and finally the practical aspects of preparing a 510(k). There will also be discussion on post-market requirements such as registration and listing, device modifications, marketing and promotion in the USA